Woodcock Washburn represents a wide range of clients in the medical device industry, including many Fortune 500 companies, and has long-standing relationships with Johnson & Johnson, Celgene, Orthovita and Dentsply. We have a thorough understanding of medical device companies and the type of intellectual property problems they face.
Our firm has successfully litigated cases involving balloon angioplasty catheters, sutures, medical procedures, medical staples, glucose meters and contact lenses, to name a few. The cases involved damages claims ranging from the millions to hundreds of millions of dollars. Here are a few cases in which we have represented medical device clients:
- DePuy, Inc. v. Zimmer Holdings, Inc. & Zimmer, Inc., (N. D. Ill.) (hip implants)
- LifeScan, Inc. v. Roche Diagnostics Corporation, (N.D. Cal.) (glucose monitors)
- Abbott Laboratories v. LifeScan, Inc. and Selfcare, Inc., (D. Mass.) (glucose monitors)
- Advanced Sterilization Products v. Jacob, (D. Mass.) (sterilization equipment)
- Related cases SciMed Life Sys., Inc. v Advanced Cardiovascular Sys., Inc., & Advanced Cardiovascular Systems, Inc. v. SciMed Life Systems, Inc., (N. D. Cal.) (balloon angioplasty catheters).
- Dentsply International, Inc. v. Kerr Manufacturing Corp., (D. Del.) (dental instruments)
- Medtronic AVE, Inc. v. Boston Scientific Corporation and SciMed Life Systems, Inc. (D. Del.) (balloon angioplasty catheters)
- Dentsply International Inc. v. Moyco Technololgies, Inc. (M.D. Pa.) (dental instruments)
- DePuy Orthopaedics v. Androphy, (N.D. Ill.) (methods & instruments for knee surgery)
- Johnson & Johnson Professional, Inc. v. Parker Medical Associates (D. Mass.) (orthopedic casting material)
Woodcock Washburn lawyers also counsel these clients on developing cost-effective, intellectual property strategies. We draft claims, prosecute patents to maximize our clients' intellectual property value, and help clients develop products that circumvent competitors' patents, which ensures them a proprietary position in the market.
Woodcock Washburn also advises clients on navigating the complex U.S. Food and Drug Administration ("FDA") regulatory processes associated with developing, manufacturing, and marketing medical devices. We provide comprehensive counseling and advocacy on FDA medical device matters ranging from product clearance and approval to post-market requirements, enforcement and compliance issues, product promotion and advertising.
Our attorneys counsel and assist our medical device clients on technology licensing and protection, strategic joint ventures and offensive and defensive litigation strategies. In addition, Woodcock Washburn lawyers also draw on our extensive experience in conducting due diligence in portfolio acquisitions, mergers and acquisitions for our clients.
